Free Trial
NYSEARCA:LABU

Direxion Daily S&P Biotech Bull 3x Shares (LABU) Price, Holdings, & News

$146.16
+2.31 (+1.61%)
(As of 07/26/2024 ET)
Today's Range
$143.65
$152.60
50-Day Range
$97.91
$148.67
52-Week Range
$48.40
$176.99
Volume
1.74 million shs
Average Volume
2.48 million shs
Market Capitalization
$1.52 billion
Assets Under Management
$1.24 billion
Dividend Yield
0.59%
Net Expense Ratio
0.96%
LABU stock logo

About Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.

LABU Stock Price History

LABU ETF News Headlines

The 3 Best Leveraged ETFs for April 2024
Nvidia’s Quiet $1 Trillion Pivot
Nvidia recently added $277 billion in market cap … IN ONE DAY.
LABU: A Really Bad Drift
Direxion Daily S&P Biotech Bull 3X Shares (LABU)
LABU: Tool For Swing Traders
Prepare for a Recession Unlike Any Other
Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.
See More Headlines
Receive LABU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Direxion
Fund Name
Direxion Daily S&P Biotech Bull 3x Shares
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:LABU
Inception Date
5/28/2015
Fund Manager
Paul Brigandi, Tony Ng
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
S&P Biotechnology Select Industry Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
168

Fund Statistics

Assets Under Management
$1.24 billion
Average Daily Volume
$1.78 million
Discount/Premium
-0.16%
Leveraged
3.00

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Rafferty Asset Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
8,459
Put Options
3,406
Call Options
5,053
Short Interest
1,020,000 shs

Miscellaneous

Beta
3.31
Creation Unit
50,000
Creation Fee
$250.00
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Direxion Daily S&P Biotech Bull 3x Shares Expenses

TypeLABUHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.75%0.56%0.54%0.51%0.51%
Other Expenses0.21%0.33%0.50%0.59%0.54%
Total Expense0.96%0.70%0.70%0.74%0.71%
Fee Waiver0.00%-0.45%-0.54%-0.69%-0.59%
Net Expense0.96%0.61%0.60%0.58%0.58%

Direxion Daily S&P Biotech Bull 3x Shares (LABU) Holdings & Exposure

Top 10 LABU Holdings

  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: 55.82%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: 41.71%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: 37.94%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: 33.91%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: 30.54%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: 27.29%
  • DREYFUS GOVT CASH MAN INS
    Holding Weight: 27.19%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: 14.38%
  • GOLDMAN FINL SQ TRSRY INST 506
    Holding Weight: 10.42%
  • GOLDMAN SACHS FIN GOV 465 INSTITUT
    Holding Weight: 5.87%

LABU Sector Exposure

LABU Industry Exposure


LABU ETF - Frequently Asked Questions

How have LABU shares performed this year?

Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $121.97 at the beginning of the year. Since then, LABU shares have increased by 19.8% and is now trading at $146.16.
View the best growth stocks for 2024 here
.

When did Direxion Daily S&P Biotech Bull 3x Shares' stock split?

Shares of Direxion Daily S&P Biotech Bull 3x Shares reverse split on Monday, December 4th 2023. The 1-20 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Who are Direxion Daily S&P Biotech Bull 3x Shares' major shareholders?

Top institutional shareholders of Direxion Daily S&P Biotech Bull 3x Shares include Traynor Capital Management Inc. (0.10%), Bank of New York Mellon Corp (0.05%) and SG Americas Securities LLC (0.02%).

How do I buy shares of Direxion Daily S&P Biotech Bull 3x Shares?

Shares of LABU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Direxion Daily S&P Biotech Bull 3x Shares own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bull 3x Shares investors own include Micron Technology (MU), NVIDIA (NVDA), Direxion Daily S&P Biotech Bear 3x Shares (LABD), Alibaba Group (BABA), ProShares UltraPro QQQ (TQQQ), Advanced Micro Devices (AMD) and Direxion Daily Semiconductors Bull 3x Shares (SOXL).

This page (NYSEARCA:LABU) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners